lymphoma

(redirected from ALCL)
Also found in: Dictionary, Thesaurus, Medical, Acronyms.
Related to ALCL: ACL

lymphoma,

a cancer of the tissue of the lymphatic systemlymphatic system
, network of vessels carrying lymph, or tissue-cleansing fluid, from the tissues into the veins of the circulatory system. The lymphatic system functions along with the circulatory system in absorbing nutrients from the small intestines.
..... Click the link for more information.
. There are two categories of lymphomas. One type is termed Hodgkin's diseaseHodgkin's disease,
a type of cancer of the lymphatic system. First identified in 1832 in England by Thomas Hodgkin, it is a type of malignant lymphoma. Incidence peaks in young adults and the elderly.
..... Click the link for more information.
, the other, non-Hodgkin's lymphoma (see lymphoma, non-Hodgkin'slymphoma, non-Hodgkin's,
any cancer of the lymphoid tissue (see lymphatic system) in which the Reed-Sternberg cells characteristic of Hodgkin's disease (the other category of lymphoma) are not present.
..... Click the link for more information.
). See also neoplasmneoplasm
or tumor,
tissue composed of cells that grow in an abnormal way. Normal tissue is growth-limited, i.e., cell reproduction is equal to cell death. Feedback controls limit cell division after a certain number of cells have developed, allowing for tissue repair
..... Click the link for more information.
.
The Columbia Electronic Encyclopedia™ Copyright © 2013, Columbia University Press. Licensed from Columbia University Press. All rights reserved. www.cc.columbia.edu/cu/cup/

lymphoma

[lim′fō·mə]
(medicine)
Any neoplasm, usually malignant, of the lymphoid tissues.
McGraw-Hill Dictionary of Scientific & Technical Terms, 6E, Copyright © 2003 by The McGraw-Hill Companies, Inc.
References in periodicals archive ?
The ALC-ALCL study was a phase II multicenter clinical study in which the response rate (primary endpoint) was assessed by the central review committee and safety was investigated in 10 patients with recurrent or refractory ALK-positive ALCL. It was conducted in three sites, led by Nagoya Medical Center, National Hospital Organization.
The authors, however, emphasized that it has not been proven that the butt implants actually caused the woman's cancer, but the case only showed a connection between textured implants and ALCL. The doctors noted that the patient's cancer had been very aggressive, developing just 12 months after she received her implants.
There was also a significant difference in the EL between mice in the CM 40 mg/kg group and Aluminum chloride (ALCL) group (P <0.0001) with a mean EL of 26.77 [+ or -] 1.67 s and 56.43 [+ or -] 2.84 s, respectively.
There is no standardized treatment for ALCL of the lung; however, current first-line therapy includes anthracyclinebased regimen, such as CHOP [10,11].
Immunohistochemistry profile may be used as an auxiliary tool to confirm the diagnosis of SIGBIC, especially to determine the differential diagnosis with ALCL. The diagnostic tests performed are
ANAPLASTIC LARGE CELL LYMPHOMA (ALCL) IN WOMEN WITH BREAST IMPLANTS: PRELIMINARY FDA FINDINGS AND ANALYSES (Jan.
In breast implant patients, >90% of these are ALK-negative ALCL, compared to 37% in non-breast implant patients [1, 8].
Histological subtypes were variable and included PTCL-NOS, ALCL, NK-cell lymphoma, and adult T-cell lymphoma/leukemia.
Identifying late peri-implant fluid after the acute postoperative time frame, however, has gained more attention from radiologists due to the possibility of anaplastic large cell lymphoma (ALCL), a very rare form of non-Hodgkin's lymphoma with a reported incidence of 3 per 100 million.
Brentuximab vedotin is a type of monoclonal antibody that targets a protein called CD30 that is found on Hodgkin's lymphoma cells and anaplastic large cell lymphoma (ALCL) cells.
Background: The t(2;5)(p23;q35) chromosomal translocation results in the expression of the fusion protein NPM/ALK that when expressed in T-lymphocytes gives rise to anaplastic large cell lymphomas (ALCL).
Objective: To study the clinicopathological and immunohistochemical features of Anaplastic Large Cell Lymphoma (ALCL).